Bayer China

Brief Company and Industry Description
Bayer China — a regional division of the German chemical and pharmaceutical conglomerate Bayer AG, operating in China in the fields of healthcare, agriculture, and materials. The company operates at the intersection of biotechnology, agrochemicals, and consumer products.

Main Products/Services and Key Markets

• Prescription and over-the-counter medications, seeds and plant protection products, functional materials.
• Key market — China (including mainland, Hong Kong, and Taiwan), with significant R&D centers and production facilities in the region.

Year of Establishment, Revenue, Number of Employees, Presence by Country

• The company's origins in the Chinese market date back to the late 19th century; significant presence has been noted since the 1980s.
• Greater China region sales in 2019 amounted to approximately €3.72 billion.
• Employees — more than 9,000 people in China by 2019.
• Presence: two global R&D centers and four production facilities in China.

What Makes Their Office/Plant/Production Interesting, What Can Be Seen and Understood About the Business

• The company's plants demonstrate the integration of high technology and local production, for example, in Shanghai or Chongqing, with an emphasis on sustainable development and digitalization.
• A visit allows one to see how an international chemical and pharmaceutical player adapts its production and innovation to the Chinese market: from the agricultural sector to medicine, R&D integration, and localization of supply chains.